IDEXX Laboratories, Inc.
IDXX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $51 | $43 | $34 | $34 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $51 | $44 | $35 | $35 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -0.4% | 11.1% | 4.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 61.8% | 62.6% | 62.4% | 59.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 35.5% | 36.9% | 35.2% | 31.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 24.8% | 26.5% | 24.3% | 22.7% |
| EPS Diluted | 3.4 | 3.63 | 2.96 | 2.62 |
| % Growth | -6.3% | 22.6% | 13% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |